Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Failure to Act on Pharmacist Recommendations and Missing Medication Review

Minneapolis, Minnesota Survey Completed on 09-11-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that pharmacist recommendations were acted upon in a timely manner for two residents reviewed for unnecessary medication use. For one resident with diagnoses including hallucinations, delusions, anxiety, and schizophrenia, the facility was unable to provide documentation of a required monthly medication regimen review for June, as confirmed by the administrator. This resident was prescribed multiple antipsychotic and antidepressant medications, and the absence of the June review indicated a lapse in the facility's process for ensuring regular pharmacist oversight. For another resident with intact cognition and psychiatric symptoms, the consulting pharmacist made a recommendation for a gradual dose reduction (GDR) of trazodone, requesting physician review and response. However, the physician did not sign or indicate acceptance or rejection of the recommendation, and there was no documentation of a patient-specific rationale if the recommendation was contraindicated. The assistant director of nursing confirmed that the recommendation was sent to the provider but no response was received, and there was uncertainty about whether any follow-up was attempted. Additionally, the facility was unable to provide a policy on pharmacy recommendations when requested.

An unhandled error has occurred. Reload 🗙